Presentation | September 18, 2015

Aseptic Processing – Achieving Sterility By Design

Source: Fedegari Group

“In an aseptic process, the drug product, container, and closure are first subjected to sterilization methods separately, as appropriate, and then brought together. Because there is no process to sterilize the product in its final container, it is critical that containers be filled and sealed in an extremely high-quality environment. Aseptic processing involves more variables than terminal sterilization.”

FDA, Aseptic Processing Guidance 2004

“Handling sterile materials in a controlled environment, in which the air supply, facility, materials, equipment and personnel are regulated to control microbial and particulate contamination to acceptable levels.”

PDA, TR# 22, 2011 revision

Sterility assurance is easy to define, but no easier to quantify:

  • In sterilization, it is estimated using a PNSU (or SAL) for each process. Actual sterilization process performance is much better than the minimum expectation of 1x10-6.
  • In aseptic processing, process simulation demonstrates a maximum contamination rate from a point-in-time evaluation.
access the Presentation!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online